BCM
IMUC

Bridgeway Capital Management’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Bridgeway Capital Management’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,750
Closed -$62K – 1591
2014
Q3 		$62K Hold
1,750
– – ﹤0.01% 1449
2014
Q2 		$78K Hold
1,750
– – ﹤0.01% 1410
2014
Q1 		$85K Hold
1,750
– – ﹤0.01% 1391
2013
Q4 		$65K Sell
1,750
-2,625
-60% -$249K ﹤0.01% 1370
2013
Q3 		$450K Hold
4,375
– – 0.02% 1086
2013
Q2 		$340K Buy
+4,375
New +$419K 0.01% 1118

Other funds holding IMUC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Callan Capital La Jolla, California $1.35B AUM 8.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $2.24B AUM 17.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return